Aimei Health Technology Co Ltd
For the period ended Sep 30, 2024. Filed Nov 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 13, 2024
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2024-06-30; filed 2024-08-09.
0001493152-24-030872
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2024-09-30; filed 2024-11-13.
0001493152-24-045119
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 27 previous paragraphs and 27 current paragraphs.
23 unchanged; 4 reworded; 0 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Reworded paragraphs (4)
Previous wording
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Current wording
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Previous wording
For the six months ended June 30, 2024, we had a net income of $1,364,592, which consisted of dividend income earned on investments held in the Trust Account of $1,827,338 offset by formation and operational costs of $462,746.
Current wording
For the nine months ended September 30, 2024, we had a net income of $2,108,102, which consisted of dividend income earned on investments held in the Trust Account of $2,770,867 offset by formation and operational costs of $662,765.
Previous wording
For the three months ended June 30, 2024, we had a net income of $609,092, which consisted of dividend income earned on investments held in the Trust Account of $918,206 offset by formation and operational costs of $309,114.
Current wording
For the three months ended September 30, 2024, we had a net income of $743,510, which consisted of dividend income earned on investments held in the Trust Account of $943,529 offset by formation and operational costs of $200,019.
Previous wording
As of June 30, 2024, we had $157,505 in our operating bank account, $71,717,186 in our Trust Account, and working capital of approximately $93,130.
Current wording
As of September 30, 2024, we had $103,559 in our operating bank account, $72,660,715 in our Trust Account, and working capital deficit of $106,889.